News from capeverdewire.com
We’ve assigned a rating of Unknown factuality to capeverdewire.com. You can read more about how we’ve determined capeverdewire.com’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top capeverdewire.com News

St. Catharines · St. CatharinesEquativ launches the AI Media Planning Agent within Maestro platform. It instantly converts media briefs into optimal campaigns activation...See the Story
Equativ Launches Media Planning Agent to Enhance Buyer Efficiency and Boost Campaign Outcomes
71% Left coverage: 7 sources

European Union · Bergisch GladbachDALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time of 14-16 d…See the Story
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting
43% Left coverage: 7 sources

Dubai, United Arab Emirates · DubaiGlobal Chief Marketing Officer Fabiola Torres details the recent extension of “Give Your Gift,” a campaign that has generated over 30 million views since its November launch.See the Story
How Gap Is Leveraging the Brand’s Katseye Success for the Holidays
67% Center coverage: 3 sources